Utility of combined solid and liquid biopsy for molecular profiling in lung adenocarcinoma: Insights from a real-world case
Lung adenocarcinoma is a subtype of NSCLC that is often associated with poor prognosis. We present a case of metastatic lung adenocarcinoma in which comprehensive genomic profiling using both solid and liquid biopsies was employed to monitor disease progression and guide targeted therapy decisions....
Saved in:
| Main Authors: | Bharat Bhosale, Gunj Bafna, Paridhy Vanniya Subramanyam, Kapil Salgia, Sadia Afreen, Jinumary John, Vyomesh Javle, Kritika Verma, N.R. Naavarasi, Sreekanth Reddy Peddagangannagari, Akhil Gorla, Giridharan Periyasamy, Kshitij Rishi, Hitesh Goswami, Vidya H. Veldore |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | The Journal of Liquid Biopsy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950195425000190 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GEFITINIB (IRESSA) IN THE TREATMENT OF BRAIN METASTASES FROM NON-SMALL CELL LUNG CARCINOMA
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01) -
A Real‐World Study: Therapeutic Outcomes of ROS1‐Positive Advanced NSCLC
by: Hanqi Yuan, et al.
Published: (2025-05-01) -
Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study
by: Alper Topal, et al.
Published: (2025-03-01) -
STUDI IN SILICO KOMPLEKS LIGAND-RESEPTOR EUGENOL DAUN BASIL (Ocimum basilicum L.) DENGAN RESEPTOR HER2 PADA NON-SMALL CELL LUNG CANCER (NSCLC) DENGAN KONTROL GEFITINIB
by: Martina Kurnia Rohmah
Published: (2017-09-01) -
Olaparib monotherapy or combination therapy in lung cancer: an updated systematic review and meta- analysis
by: Sajjad Hajihosseini, et al.
Published: (2025-03-01)